Rectal Diseases  >>  sonolisib (PX 866)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
sonolisib (PX 866) / Pfizer
NCT01252628: Phase 1 and 2 Study of PX-866 and Cetuximab

Checkmark In pts with metastatic CRC or recurrent/metastatic SCCHN
Jun 2014 - Jun 2014: In pts with metastatic CRC or recurrent/metastatic SCCHN
Checkmark P1 data
Nov 2011 - Nov 2011: P1 data
Completed
1/2
178
US, Canada
PX-866 (SCCHN), Cetuximab (SCCHN), Erbitux, PX-866 (CRC), Cetuximab (CRC)
Cascadian Therapeutics Inc.
Incurable Metastatic Colorectal Carcinoma, Incurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
11/13
01/14

Download Options